| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
AnazaoHealth Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tampa, FL. To find more information about AnazaoHealth Corporation, please visit www.anazaohealth.com
Clinical Resources Group is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kaléo is dedicated to inventing, manufacturing and commercializing life-transforming products that empower patients and families to live fuller, bolder lives. We are committed to developing solutions that support the healthcare provider-patient relationship, improving access to our products.
Endo Optiks Inc is a Little Silver, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.